Oncology News | pharmaphorum

News

There are three types of white blood cells. T lymphocytes, B lymphocytes and natural killer cells.

Natural killer cells 'a hundred times cheaper' than CAR-T

Creating cancer therapies based around natural killer cells could offer similar levels of efficacy to CAR-T therapies, but at around one hundredth of the cost.

News

J&J files next generation prostate cancer drug in Europe

After having filed its new prostate cancer drug apalutamide with the FDA in October, Johnson & Johnson have now submitted the drug to Europe’s EMA.

News

Belgium chosen for first J&J ‘JLABS’ incubator in Europe

Johnson & Johnson is rolling out its ‘no strings attached’ innovation incubator project JLABS to Europe – and has chosen a site in Belgium with a link to the company’s history.

News

Roche’s Tecentriq + Avastin racks up another combination suc...

Roche has produced new data showing a combination of Tecentriq and older drug Avastin is more effective than standard therapy for delaying progression in kidney cancer patients.

News

BMS strikes back with lung cancer combo success

Just as it looked like Bristol Myers Squibb might never catch up with its rivals in frontline lung cancer treatment, the company has achieved success in a new combination.

News